Maspin increases extracellular plasminogen activator activity associated with corneal fibroblasts and myofibroblasts

被引:13
|
作者
Warejcka, Debra J. [1 ]
Narayan, Malathi [1 ]
Twining, Sally S. [1 ,2 ]
机构
[1] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Dept Ophthalmol, Milwaukee, WI 53226 USA
基金
美国国家卫生研究院;
关键词
maspin; cornea; turnover; urinary-type plasminogen activator; tissue-type plasminogen activator; plasminogen activator inhibitor-1; fibroblast; myofibroblast; UROKINASE-TYPE; MATRIX METALLOPROTEINASES; REPAIR PHENOTYPE; BLOOD MONOCYTES; DEFICIENT MICE; CELLS; EXPRESSION; INHIBITORS; CONVERSION; RECEPTOR;
D O I
10.1016/j.exer.2011.07.008
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Maspin, an inhibitor of cell migration and a stimulator of adhesion of cells to the ECM, is synthesized and released by corneal keratocytes into the extracellular matrix. When the cornea is wounded, the quiescent stromal keratocytes underlying the wound undergo apoptosis and cells adjacent to this apoptotic area convert to fibroblasts or myofibroblasts. This study explores the effect of extracellular maspin on the plasminogen plasminogen activator system of corneal stromal cells following wounding. Treatment of corneal fibroblasts and myofibroblasts with r-maspin increased extracellular but not cell-associated tissue-type plasminogen activator (tPA), urinary-type plasminogen activator (uPA) or plasminogen activator inhibitor-1 (PAI-1). Despite the extracellular increase in PAI-1, the net effect of maspin treatment was an increase in plasminogen activation. At physiological levels, maspin did not alter uPA or tPA mRNA levels, in these cells. The increase in pro and active uPA was due to decreased clearance in the presence of maspin for myofibroblasts but not for fibroblasts. The clearance of pro and active tPA was normal in fibroblasts indicating different mechanisms for the increase of these homologous enzymes in the two cell types. Increased generation of plasmin by maspin treated corneal stromal fibroblasts and myofibroblasts led to conversion of plasminogen to active plasmin degradation products and angiostatin-like molecules. This study suggests that extracellular maspin increased pro and active uPA and tPA released by corneal fibroblasts and myofibroblasts on the short time scale of 1-4 h, but by 24 h there was no increase over the levels produced without maspin. This augmentation of plasminogen activator activity increases plasmin activation and angiostatin generation. It further indicates that the effect of maspin on uPA and tPA levels is cell type dependent. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:618 / 627
页数:10
相关论文
共 50 条
  • [41] Quebec Platelet Disorder Is Associated With Greater Than Expected Increases In Urokinase Plasminogen Activator In Granulocytes and Monocytes
    Blavignac, Jessica
    Tasneem, Subia
    Paterson, Andrew D.
    Waye, John S.
    Bharaj, Bhupinder
    Rivard, Georges E.
    Hayward, Catherine P. M.
    BLOOD, 2013, 122 (21)
  • [42] DEGLYCOSYLATION INCREASES THE FIBRINOLYTIC-ACTIVITY OF A DELETION MUTANT OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR
    WILHELM, J
    KALYAN, NK
    LEE, SG
    HUM, WT
    RAPPAPORT, R
    HUNG, PP
    THROMBOSIS AND HAEMOSTASIS, 1990, 63 (03) : 464 - 471
  • [43] MATRIGEL INCREASES UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA) ACTIVITY IN HUMAN OSTEOSARCOMA CELLS
    GHOSH, S
    YAN, L
    MCGUIRE, MH
    PATTERSON, EB
    YEE, JA
    MOLECULAR BIOLOGY OF THE CELL, 1995, 6 : 1607 - 1607
  • [44] Acetaldehyde increases the activity and gene expression of urokinase type plasminogen activator in a hepatic stellate cell line
    Rodríguez-Fragoso, L
    Alvarez, R
    Reyes-Esparza, JA
    Garcés, ME
    TOXICOLOGY, 1999, 137 (01) : 1 - 11
  • [45] In-vivo imaging of tumor associated urokinase-type plasminogen activator activity
    Hsiao, Jong-Kai
    Law, Benedict
    Weissleder, Ralph
    Tung, Ching-Hsuan
    JOURNAL OF BIOMEDICAL OPTICS, 2006, 11 (03)
  • [46] ONCOSTATIN-M STIMULATES UROKINASE-TYPE PLASMINOGEN-ACTIVATOR ACTIVITY IN HUMAN SYNOVIAL FIBROBLASTS
    HAMILTON, JA
    LEIZER, T
    PICCOLI, DS
    ROYSTON, KM
    BUTLER, DM
    CROATTO, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 180 (02) : 652 - 659
  • [47] TRANSFORMING GROWTH-FACTOR-BETA ALTERS PLASMINOGEN-ACTIVATOR ACTIVITY IN HUMAN-SKIN FIBROBLASTS
    LAIHO, M
    SAKSELA, O
    KESKIOJA, J
    EXPERIMENTAL CELL RESEARCH, 1986, 164 (02) : 399 - 407
  • [48] Inhibition by Epigallocatechin Gallate of IL-1-Induced Urokinase-Type Plasminogen Activator Expression and Collagen Degradation by Corneal Fibroblasts
    Sugioka, Koji
    Yoshida, Koji
    Murakami, Junko
    Itahashi, Motoki
    Mishima, Hiroshi
    Nishida, Teruo
    Kusaka, Shunji
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (08) : 2895 - 2903
  • [49] PLASMINOGEN-ACTIVATOR INHIBITOR IS ASSOCIATED WITH THE EXTRACELLULAR-MATRIX OF CULTURED BOVINE SMOOTH-MUSCLE CELLS
    KNUDSEN, BS
    HARPEL, PC
    NACHMAN, RL
    JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (04): : 1082 - 1089
  • [50] EXTRACELLULAR RELEASE OF TISSUE PLASMINOGEN-ACTIVATOR IS INCREASED WITH THE PHAGOCYTIC-ACTIVITY OF THE RETINAL-PIGMENT EPITHELIUM
    TRIPATHI, BJ
    PARK, JK
    TRIPATHI, RC
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1989, 30 (12) : 2470 - 2473